Every 10-Q that TRILINC GB IMPACT FD UT A (TRLC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow TRLC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRLC filings page.
TriLinc Global Impact Fund, LLC reported total assets of $282.8 million and net assets of $271.9 million as of June 30 2026, with investments at fair value of $262.6 million. Net asset value was about $5.70 per unit, essentially unchanged from $5.71 at December 31 2025.
For the six months ended June 30 2026, the fund generated net investment income of $3.0 million but recorded $3.7 million of unrealized depreciation, leading to a net decrease in net assets from operations of $0.7 million, versus a $3.3 million increase a year earlier. Total investment income declined to $9.7 million from $13.7 million.
The portfolio is highly concentrated: the largest loan, a PIK-only position in a Mexico waste-to-fuels processor, was $78.1 million, or 29.7% of investments; the five largest positions represented 60.9%. All investments are Level 3 fair value measurements, and many positions are on a Watch List, in default, on non-accrual, in restructuring or bankruptcy. The company also highlights historical issues with former sub-advisor IIG, including a fraudulent loan participation and an SEC antifraud judgment, as continuing credit and recovery risks.
TriLinc Global Impact Fund, LLC reported largely flat net assets of $272.7M as of March 31, 2026, versus $272.6M at December 31, 2025. Net asset value per unit was approximately $5.72, slightly above $5.71 at year-end.
For the quarter, total investment income was $4.0M compared with $6.3M a year earlier, producing net investment income of $0.5M and net income of $0.1M, well below the prior-year period. The portfolio’s fair value was $263.3M, entirely valued using Level 3 inputs, with significant concentration: the largest loan, a paid-in-kind facility to Blue Arrow Biojet Holdings, was $74.4M, or about 28% of investments, while the five largest loans represented about 59% of the portfolio. The fund highlights ongoing credit and liquidity risks, including multiple Watch List, defaulted and bankruptcy positions, heavy use of payment-in-kind interest and exposure to past issues with former sub-advisor IIG.
TriLinc Global Impact Fund (TRLC) filed its Q3 2025 report showing lower net assets and NAV driven by unrealized losses. Net assets were $273,358,853, down from $281,135,972 at year-end. NAV per unit was $5.729 versus $5.892, based on 47,777,985 units outstanding.
For the quarter, total investment income was $2,615,805 against expenses of $3,090,584, resulting in a net investment loss of $474,779 and a total operating loss of $11,057,562 as unrealized depreciation weighed on results. For the nine months, net investment income was $6,336,174, offset by $14,032,422 of unrealized depreciation, leading to a $7,770,119 decrease in net assets from operations. Investments at fair value were $260,014,676 versus amortized cost of $334,072,701, reflecting valuation pressures.
Liabilities rose to $9,485,777, including a $2,876,926 repurchase obligation and $363,000 accrued distribution and other fees. The company records these fees under GAAP but does not deduct the accrual when determining quarterly NAV. Management noted it is negotiating with a borrower to amend loan terms and extend a maturity date.